Skip to main content

ADVERTISEMENT

Peripheral arterial disease

Review
09/05/2008
The prevalence of peripheral arterial disease (PAD) in the adult population is as high as 12–18%. Conservative treatments, including risk factor modification, supervised exercise training and medical therapy are indicated in patients whose...
The prevalence of peripheral arterial disease (PAD) in the adult population is as high as 12–18%. Conservative treatments, including risk factor modification, supervised exercise training and medical therapy are indicated in patients whose...
The prevalence of peripheral...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
Multiple large prospective randomized trials have compared the treatment of patients that have arteriosclerotic occlusive disease or diabetes with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors versus placebo.
Multiple large prospective randomized trials have compared the treatment of patients that have arteriosclerotic occlusive disease or diabetes with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors versus placebo.
Multiple large prospective...
09/05/2008
Vascular Disease Management
Case Series
09/05/2008
With the increase in the use of endovascular treatment of peripheral arterial disease, the heretofore underappreciated dynamics of arterial movement are now known to be important in long-term outcomes. Several forces are known to exert...
With the increase in the use of endovascular treatment of peripheral arterial disease, the heretofore underappreciated dynamics of arterial movement are now known to be important in long-term outcomes. Several forces are known to exert...
With the increase in the use of...
09/05/2008
Vascular Disease Management